Ahmed, SK et al. Antimicrobial resistance: impacts, challenges and future prospects. J.Med. Surg. Public health 2100081 (2024).
Naghavi, M. et al. Global burden of bacterial antimicrobial resistance 1990-2021: a systematic analysis with forecasts to 2050. Lancet 4041199-1226 (2024).
Jonas, OB, Irwin, A., Berthe, FCJ, Le Gall, FG & Marquez, PV Drug-resistant infections: a threat to our economic future. World Bank Report https://documents.worldbank.org/en/publication/documents-reports/documentdetail/323311493396993758 (2017).
Helaine, S., Conlon, BP, Davis, KM and Russell, DG Host stress drives tolerance and persistence: the scourge of antimicrobial therapies. Cell host microbe 32852-862 (2024).
Cox, G. & Wright, GD Intrinsic antibiotic resistance: mechanisms, origins, challenges and solutions. Int. J.Med. Microbiol. 303287-292 (2013).
Balaban, NQ et al. Definitions and guidelines for research on antibiotic persistence. Nat. Reverend Microbiol. 17441-448 (2019).
Darby, EM et al. Molecular mechanisms of antibiotic resistance revisited. Nat. Reverend Microbiol. 21280-295 (2023).
Brauner, A., Fridman, O., Gefen, O. and Balaban, NQ Distinguishing resistance, tolerance and persistence to antibiotic treatment. Nat. Reverend Microbiol. 14320-330 (2016).
Ronneau, S., Hill, PW and Helaine, S. Antibiotic persistence and tolerance: not one and the same thing. Curr. Notice. Microbiol. 6476-81 (2021).
Araten, AH et al. Cephalosporin resistance, tolerance and approaches to improve their activities. J. Antibiot. 77135-146 (2024).
Fang, X. & Allison, KR Resuscitation dynamics reveal persistent partitioning after antibiotic treatment. Mol. System. Biol. 19e11320 (2023).
Marques, CNH, Morozov, A., Planzos, P. & Zelaya, H.M. The fatty acid signaling molecule cis-2-decenoic acid increases metabolic activity and returns persister cells to an antimicrobial-sensitive state. Appl. Approx. Microbiol. 806976-6991 (2014).
Moyed, HS & Bertrand, KP hipA, a newly recognized gene of Escherichia coli K-12 which affects the frequency of persistence after inhibition of murein synthesis. J. Bacteriol. 155768-775 (1983).
Lacerda Mariano, L. & Ingersoll, MA The immune response to bladder infection. Nat. Reverend Urol. 17439-458 (2020).
Kochanowski, K., Morinishi, L., Altschuler, SJ & Wu, LF Drug persistence – from antibiotics to cancer therapies. Curr. Notice. System. Biol. 101–8 (2018).
Ma, M. & Kim, M. High-resolution, high-throughput detection of hidden antibiotic resistance with the dilution and delay (DnD) susceptibility test. Nat. Common. 173641 (2026).
Olivares Pacheco, JA et al. The intrinsic resistome of pathogenic bacteria. In front. Microbiol. 4103 (2013).
Google Scholar
Kadeřábková, N., Mahmood, AJS & Mavridou, DAI Antibiotic susceptibility testing using minimum inhibitory concentration (MIC) tests. npj Antimicrobial. Resist. 237 (2024).
Neuhaus, S. et al. Towards harmonized terminology: a glossary for biocide susceptibility testing. Pathogens 111455 (2022).
Fernández, L. & Hancock, REW Adaptive and mutational resistance: role of porins and efflux pumps in drug resistance. Clin. Microbiol. Round. 25661-681 (2012).
Niu, H., Gu, J. and Zhang, Y. Persistent bacteria: molecular mechanisms and therapeutic development. Signal transduction. Target. There. 9174 (2024).
Orman, MA & Brynildsen, MP Dormancy is neither necessary nor sufficient for bacterial persistence. Antimicrobial. Agents Chemother. 573230-3239 (2013).
Hill, PWS et al. The vulnerable versatility of Salmonella antibiotics persists during infection. Cell host microbe 291757-1773.e10 (2021).
Mouton, JW et al. The role of pharmacokinetics/pharmacodynamics in defining clinical MIC endpoints: the EUCAST approach. Clin. Microbiol. Infect. 18E37-E45 (2012).
MacLean, RC and San Millan, A. The evolution of antibiotic resistance. Science 3651082-1083 (2019).
Kolář, M., Urbánek, K. & Látal, T. Selective pressure to antibiotics and the development of bacterial resistance. Int. J. Antimicrobial. Agents 17357-363 (2001).
Pandey, S. et al. Antibiotic resistance in livestock, the environment and humans: One Health perspective. J.Anim. Sci. Technology. 66266-278 (2024).
Djordjevic, SP et al. Genomic surveillance of antimicrobial resistance – a One Health perspective. Nat. Reverend Genet. 25142-157 (2024).
von Wintersdorff, CJH et al. Dissemination of antimicrobial resistance in microbial ecosystems by horizontal gene transfer. In front. Microbiol. 7173 (2016).
Google Scholar
Li, D. et al. Dominance of Escherichia coli ST73, ST95, ST127 and ST131 sequence types in Australian urine isolates: a genomic analysis of F-plasmid-related antimicrobial resistance and virulence. Microbe. Genome. 9001068 (2023).
Google Scholar
Hossain, M. et al. Genotype–phenotype correlation of β-lactamase-producing uropathogens Escherichia coli (UPEC) of Bangladesh. Sci. representative 1014549 (2020).
Li, D. et al. Genomic comparisons of Escherichia coli ST131 from Australia. Microbe. Genome. 7000721 (2021).
Hussain, A. et al. Multidrug-resistant uropathogen Escherichia coli from a region of India where urinary tract infections are endemic: genotypic and phenotypic characteristics of sequence type 131 isolates of the extended-spectrum β-lactamase-producing lineage CTX-M-15. Antimicrobial. Agents Chemother. 566358-6365 (2012).
Li, D., Reid, CJ, Kudinha, T., Jarocki, VM and Djordjevic, SP Genomic analysis of trimethoprim-resistant extraintestinal pathogens Escherichia coli and recurrent urinary tract infections. Microbe. Genome. 6e000475 (2020).
Google Scholar
Poey, ME, de los Santos, E., Aznarez, D., García-Laviña, CX & Laviña, M. Genetics of trimethoprim resistance in cotrimoxazole-resistant uropathogens Escherichia coli: integrons, transposons and monogenic cassettes. In front. Microbiol. 151395953 (2024).
Blahna, MT et al. The role of horizontal gene transfer in the spread of trimethoprim-sulfamethoxazole resistance in uropathogens Escherichia coli in Europe and Canada. J. Antimicrobial. Chemother. 57666-672 (2006).
Kneis, D. et al. Trimethoprim resistance in surface water and wastewater is mediated by contrasting variants of the dfrB gene. ISME J. 171455-1466 (2023).
Venkatesan, M. et al. Molecular mechanism of plasmid resistance to sulfonamide antibiotics. Nat. Common. 144031 (2023).
Yu, K. et al. Global spread characteristics of CTX-M-type extended-spectrum β-lactamases: a genomic epidemiological analysis. Drug resistance. Updates…
Gn Health
